| 000 | 00918 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518044450.0 | ||
| 264 | 0 | _c20200303 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a2324-8645 | ||
| 024 | 7 |
_a10.1089/humc.2019.29045.bfs _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aGene Therapy Briefs. _h[electronic resource] |
| 260 |
_bHuman gene therapy. Clinical development _c06 2019 |
||
| 300 |
_a43-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscular Atrophy, Spinal _xgenetics |
| 650 | 0 | 4 |
_aSurvival of Motor Neuron 1 Protein _xgenetics |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tHuman gene therapy. Clinical development _gvol. 30 _gno. 2 _gp. 43-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/humc.2019.29045.bfs _zAvailable from publisher's website |
| 999 |
_c29814669 _d29814669 |
||